Global Veterinary Anthrax Vaccines Market Insights, Forecast to 2025

Published On: Oct 2018

Format: PDF

Publisher: QY Research

Pages: 119

Report ID: 180936

In 2017, the global Veterinary Anthrax Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Veterinary Anthrax Vaccines market based on company, product type, application and key regions.

This report studies the global market size of Veterinary Anthrax Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Anthrax Vaccines in these regions.
This research report categorizes the global Veterinary Anthrax Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Veterinary Anthrax Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Veterinary Anthrax Vaccines include
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC

Market Size Split by Type
Cell Free PA Vaccines
Live Vaccines
Market Size Split by Application
Cow
Sheep
Swine
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Veterinary Anthrax Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Veterinary Anthrax Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary Anthrax Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veterinary Anthrax Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Veterinary Anthrax Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Veterinary Anthrax Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Anthrax Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Veterinary Anthrax Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Anthrax Vaccines Market Size Growth Rate by Type
1.4.2 Cell Free PA Vaccines
1.4.3 Live Vaccines
1.5 Market by Application
1.5.1 Global Veterinary Anthrax Vaccines Market Size Growth Rate by Application
1.5.2 Cow
1.5.3 Sheep
1.5.4 Swine
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Veterinary Anthrax Vaccines Market Size
2.1.1 Global Veterinary Anthrax Vaccines Revenue 2016-2025
2.1.2 Global Veterinary Anthrax Vaccines Sales 2016-2025
2.2 Veterinary Anthrax Vaccines Growth Rate by Regions
2.2.1 Global Veterinary Anthrax Vaccines Sales by Regions
2.2.2 Global Veterinary Anthrax Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Veterinary Anthrax Vaccines Sales by Manufacturers
3.1.1 Veterinary Anthrax Vaccines Sales by Manufacturers
3.1.2 Veterinary Anthrax Vaccines Sales Market Share by Manufacturers
3.1.3 Global Veterinary Anthrax Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Veterinary Anthrax Vaccines Revenue by Manufacturers
3.2.1 Veterinary Anthrax Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Veterinary Anthrax Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Veterinary Anthrax Vaccines Price by Manufacturers
3.4 Veterinary Anthrax Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Anthrax Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Veterinary Anthrax Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Veterinary Anthrax Vaccines Sales by Type
4.2 Global Veterinary Anthrax Vaccines Revenue by Type
4.3 Veterinary Anthrax Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Veterinary Anthrax Vaccines Breakdown Data by Application

6 North America
6.1 North America Veterinary Anthrax Vaccines by Countries
6.1.1 North America Veterinary Anthrax Vaccines Sales by Countries
6.1.2 North America Veterinary Anthrax Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Anthrax Vaccines by Type
6.3 North America Veterinary Anthrax Vaccines by Application
6.4 North America Veterinary Anthrax Vaccines by Company

7 Europe
7.1 Europe Veterinary Anthrax Vaccines by Countries
7.1.1 Europe Veterinary Anthrax Vaccines Sales by Countries
7.1.2 Europe Veterinary Anthrax Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Anthrax Vaccines by Type
7.3 Europe Veterinary Anthrax Vaccines by Application
7.4 Europe Veterinary Anthrax Vaccines by Company

8 Asia Pacific
8.1 Asia Pacific Veterinary Anthrax Vaccines by Countries
8.1.1 Asia Pacific Veterinary Anthrax Vaccines Sales by Countries
8.1.2 Asia Pacific Veterinary Anthrax Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Veterinary Anthrax Vaccines by Type
8.3 Asia Pacific Veterinary Anthrax Vaccines by Application
8.4 Asia Pacific Veterinary Anthrax Vaccines by Company

9 Central & South America
9.1 Central & South America Veterinary Anthrax Vaccines by Countries
9.1.1 Central & South America Veterinary Anthrax Vaccines Sales by Countries
9.1.2 Central & South America Veterinary Anthrax Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Veterinary Anthrax Vaccines by Type
9.3 Central & South America Veterinary Anthrax Vaccines by Application
9.4 Central & South America Veterinary Anthrax Vaccines by Company

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Anthrax Vaccines by Countries
10.1.1 Middle East and Africa Veterinary Anthrax Vaccines Sales by Countries
10.1.2 Middle East and Africa Veterinary Anthrax Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Anthrax Vaccines by Type
10.3 Middle East and Africa Veterinary Anthrax Vaccines by Application
10.4 Middle East and Africa Veterinary Anthrax Vaccines by Company

11 Company Profiles
11.1 Agrovet
11.1.1 Agrovet Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.1.4 Veterinary Anthrax Vaccines Product Description
11.1.5 Recent Development
11.2 Bayer Sanidad Animal
11.2.1 Bayer Sanidad Animal Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.2.4 Veterinary Anthrax Vaccines Product Description
11.2.5 Recent Development
11.3 Biogenesis Bago SA
11.3.1 Biogenesis Bago SA Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.3.4 Veterinary Anthrax Vaccines Product Description
11.3.5 Recent Development
11.4 Botswana Vaccine Institute
11.4.1 Botswana Vaccine Institute Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.4.4 Veterinary Anthrax Vaccines Product Description
11.4.5 Recent Development
11.5 Central Veterinary Control and Research Institute
11.5.1 Central Veterinary Control and Research Institute Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.5.4 Veterinary Anthrax Vaccines Product Description
11.5.5 Recent Development
11.6 Centro Diagnostico Veterinario
11.6.1 Centro Diagnostico Veterinario Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.6.4 Veterinary Anthrax Vaccines Product Description
11.6.5 Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.7.4 Veterinary Anthrax Vaccines Product Description
11.7.5 Recent Development
11.8 Colorado Serum Company
11.8.1 Colorado Serum Company Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.8.4 Veterinary Anthrax Vaccines Product Description
11.8.5 Recent Development
11.9 Empresa Colombiana de Productos Veterinarios S.A
11.9.1 Empresa Colombiana de Productos Veterinarios S.A Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.9.4 Veterinary Anthrax Vaccines Product Description
11.9.5 Recent Development
11.10 Indian Immunologicals Limited
11.10.1 Indian Immunologicals Limited Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Veterinary Anthrax Vaccines
11.10.4 Veterinary Anthrax Vaccines Product Description
11.10.5 Recent Development
11.11 Institute for Biological Products
11.12 Intervac (PVT) Ltd
11.13 JOVAC

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Veterinary Anthrax Vaccines Raw Material
13.1.2 Veterinary Anthrax Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer